The European Federation of Pharmaceutical Industries and Associations (EFPIA) has issued a response to the recently published study in the British Medical Journal (BMJ) on the efficacy of cancer medicines, noting the importance of real-world data.
Response
According to a statement from the EFPIA between 1991 and 2011 the rates of death from cancer have fallen by 21% across the five EU countries — UK, Germany, France, Spain and Italy. With two out of three cancer patients surviving at least five years now.